AngioDynamics Inc
XBER:UG2
AngioDynamics Inc
XBER:UG2
Price:
10.8
EUR
Market Cap:
€1.7B
Relative Value
The Relative Value of one
UG2
stock under the Base Case scenario is
9.59
EUR.
Compared to the current market price of 10.8 EUR,
AngioDynamics Inc
is
Overvalued by 11%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
UG2
Relative Value
Base Case
9.59
EUR
Overvaluation 11%
Multiples Across Competitors
UG2 Competitors Multiples
AngioDynamics Inc Competitors
AngioDynamics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
AngioDynamics Inc
XBER:UG2
|
459m EUR | 1.5 | -16.6 | 133.9 | -20.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
191.5B USD | 4.3 | 29.3 | 16.8 | 23.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
175B USD | 17.4 | 61.3 | 46.5 | 57.2 | |
| US |
|
Stryker Corp
NYSE:SYK
|
132.3B USD | 5.3 | 40.7 | 20.8 | 25.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
114.2B USD | 3.2 | 24.8 | 13.6 | 19.9 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103.3B USD | 5.1 | 35.6 | 20.9 | 28.1 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
44.2B EUR | 1.9 | 21 | 11.7 | 16.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49.4B USD | 8.2 | 46.1 | 25.4 | 27.8 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
47.9B USD | 11.1 | 45.2 | 32.1 | 35.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
46.5B USD | 2.1 | 26.4 | 10.3 | 17.5 | |
| US |
|
Resmed Inc
NYSE:RMD
|
35B USD | 6.5 | 23.5 | 16.6 | 18.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
